Pre-launch drug access programmes can help patients access investigational therapies before they receive regulatory approval and are launched commercially. This option is generally used for therapies ...
The complex and changing needs of patients with life-threatening conditions has led many health authorities to introduce early access programmes. These pathways offer patients who have severe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results